Krishnaswamy kasturirangan, Chancellor of Jawaharlal Nehru University, Delhi

Washington [US], September 3 : Treatment for over 80 per cent of breast cancer survivors does not end with surgery, radiation, and chemotherapy. Instead, doctors advise them to take medication to inhibit sex hormones, which can fuel tumour growth and cause recurrence, for the next five to ten years.The medications are life-saving: They have been proven to reduce the risk of cancer recurrence by up to half in patients with hormone receptor-positive (HR+) tumours, the most common kind of breast cancer. Despite their stated benefits, 40 per cent of people discontinue them too soon, and a third take them less frequently than prescribed.New CU Boulder research, published this month in the Journal of Clinical Oncology, sheds light on why that is and what doctors and the health care system can do about it.It found that, overall, interventions can increase medication adherence by nearly 1.5 times. But some strategies work better than others.“Our bottom-line finding is that there are strategies that do work in supporting women to take these life-extending medications, and that we as a cancer care community need to do better,” said senior author Joanna Arch, a professor in the Department of Psychology and Neuroscience and member of the CU Cancer Center on the Anschutz Medical Campus.Arch noted these so-called “adjuvant endocrine therapies,” like the estrogen-blockers Tamoxifen and aromatase inhibitors, can be costly and come with a host of side effects, including weight gain, sexual side effects, joint pain, depression and sleeplessness.“Imagine going from your normal estrogen activity to little or no estrogen within days. That’s what these medications do,” she said. “But the women who take them as prescribed also have lower recurrence rates and live longer. It’s a dilemma.”As more next-generation cancer drugs, including chemotherapy agents, shift from infusions provided in a clinic to oral therapies taken at home, the medical community has grown increasingly interested in developing ways to make sure patients take their pills.In a sweeping meta-analysis, Arch and her colleagues analyzed 25 studies representing about 368,000 women to gain insight into what works and what doesn’t. The study found that cost-cutting policy changes, such as providing generic alternatives or requiring insurance companies to cover pills at the same level as infusions, consistently worked. Such “oral parity laws” have been passed in 43 states in recent years.In one study, participants were asked to create stickers to put on their pill boxes.Mobile apps and texts to remind patients to take their medication and psychological/coping strategies also yielded modest improvements.The study’s findings around managing side effects were complicated: Simply educating women on side effects, via pamphlets or verbal explanations, generally failed to increase the likelihood that women took their medication as directed.But things such as physical therapy, exercise and behavioral counseling aimed at alleviating or managing side effects often worked.“Education in and of itself is not enough. That is a clear finding,” said Arch, suggesting that doctors write referrals to practitioners who specialize in side effects and follow up with appointment reminders. “Most oncologists, I believe, don’t realize how low adherence is for these women. They assume that if they write the prescription, it’s being taken.”One study included in the meta-analysis was Arch’s own.In it, women were asked to identify their primary motivation for taking their medication—whether it was living to see their child or grandchild grow up, pursuing their art or running a marathon someday. Via an online program, they created a sticker with a photo representing that goal, and the words “I take this for…” below it. Then, they stuck it on their pill box.Participants were more likely to take their pills, at least for the first month, than those who didn’t.“Even just a tiny thing like this can help,” said Arch.Notably, very few studies looked at whether treating depression can help. Arch, aiming to fill this gap, recently launched her own pilot trial.“One of the most consistent predictors of not adhering to any medication is depression,” she said. “Depression taps motivation.”Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Krishnaswamy KasturiranganFOLLOW

Krishnaswamy kasturirangan, Latest News

Washington DC [US], September 3 : A review paper published in the journal Foods describes a study that provides ... ...

Dubai [UAE], September 3 (ANI/WAM): HealthPlus Fertility, a Mubadala Health partner, has celebrated another successful HealthPlus Middle East Fertility ... ...

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not ... ...

Miyagi Prefecture [Japan], September 3 : Researchers all across the world are looking for tangible clues of what is ... ...

Bengaluru, Sep 3 It is no secret in Karnataka that the Congress government is trying to poach MLAs ... ...

New Delhi, Sep 3 Indian Navy's guided missile destroyer INS Delhi departed Colombo on Sunday after a two-day ... ...

Lausanne [Switzerland], September 3 : According to a study, treating obstructive sleep apnoea (OSA) can help reduce nocturnal heartburn, ... ...

Washington [US], September 3 : Treatment for over 80 per cent of breast cancer survivors does not end with ... ...